Follow
Melissa Raven
Melissa Raven
Verified email at adelaide.edu.au
Title
Cited by
Cited by
Year
Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence
J Le Noury, JM Nardo, D Healy, J Jureidini, M Raven, C Tufanaru, ...
Bmj 351, 2015
3782015
The increased use of antidepressants has contributed to the worldwide reduction in suicide rates
G Isacsson, CL Rich, J Jureidini, M Raven
The British Journal of Psychiatry 196 (6), 429-433, 2010
992010
Addiction: Not just brain malfunction.
D Heim
Nature 507 (7490), 2014
842014
Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: systematic review.
M Whitely, M Raven, S Timimi, J Jureidini, J Phillimore, J Leo, J Moncrieff, ...
Journal of Child Psychology and Psychiatry, 2018
662018
Mental health messages in prominent mental health apps
L Parker, L Bero, D Gillies, M Raven, B Mintzes, J Jureidini, Q Grundy
The Annals of Family Medicine 16 (4), 338-342, 2018
662018
A health app developer’s guide to law and policy: a multi-sector policy analysis
L Parker, T Karliychuk, D Gillies, B Mintzes, M Raven, Q & Grundy
BMC Medical Informatics and Decision Making 17 (141), 2017
622017
Dimensions of control in bulimia and anorexia nervosa: Internal control, desire for control, or fear of losing self-control?
M Tiggemann, M Raven
Eating Disorders 6 (1), 65-71, 1998
531998
Video-based telehealth in Australian primary health care: current use and future potential
M Raven, C Butler, P Bywood
Australian Journal of Primary Health 19 (4), 283-286, 2013
522013
The" Hot potato" of mental health app regulation: a critical case study of the australian policy arena
L Parker, L Bero, D Gillies, M Raven, Q Grundy
International journal of health policy and management 8 (3), 168, 2019
342019
Antidepressant prescribing and suicide/self-harm by young Australians: regulatory warnings, contradictory advice, and long-term trends
M Whitely, M Raven, J Jureidini
Frontiers in psychiatry 11, 513629, 2020
242020
Drinkers, non‐drinkers and deferrers: Reconsidering the beer/footy couplet amongst Australian Rules football fans1
K Thompson, C Palmer, M Raven
The Australian Journal of Anthropology 22 (3), 388-408, 2011
242011
Psychotropic marketing practices and problems: Implications for DSM-5
M Raven, P Parry
The Journal of nervous and mental disease 200 (6), 512-516, 2012
232012
Trends in prescription of psychotropic medications to children and adolescents in Australian primary care from 2011 to 2018
J Klau, CDO Bernardo, DA Gonzalez-Chica, M Raven, J Jureidini
Australian & New Zealand Journal of Psychiatry 56 (11), 1477-1490, 2022
212022
Study 329 continuation phase: safety and efficacy of paroxetine and imipramine in extended treatment of adolescent major depression
J Le Noury, JM Nardo, D Healy, J Jureidini, M Raven, C Tufanaru, ...
International Journal of Risk & Safety in Medicine 28 (3), 143-161, 2016
182016
Improving the integration of mental health services in primary health care at the macro level
P Bywood, L Brown, M Raven
Adelaide: Primary Health Care Research and Information Service, 2015
172015
Novel melatonin-based treatments for major depression
J Jureidini, M Raven
The Lancet 379 (9812), 216-217, 2012
162012
Current'best practice'interventions for gambling problems: A theoretical and empirical review
J O’Connor, R Ashenden, M Raven, S Allsop
Melbourne: Department of Human Services, 2000
162000
‘Prodromal’diagnosis of psychosis: ethical problems in research and clinical practice
M Raven, GW Stuart, J Jureidini
Australian & New Zealand Journal of Psychiatry 46 (1), 64-65, 2012
152012
Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
J Jureidini, B Mintzes, M Raven
Pharmacoeconomics 26, 557-566, 2008
142008
Health of grey nomads: On the move and under the health sector radar
M Raven
Australian Journal of Rural Health 24 (3), 182-187, 2016
132016
The system can't perform the operation now. Try again later.
Articles 1–20